Creo Medical (UK) Market Value
| CREO Stock | 16.00 0.13 0.81% |
| Symbol | Creo |
Creo Medical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Creo Medical's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Creo Medical.
| 09/03/2024 |
| 12/02/2024 |
If you would invest 0.00 in Creo Medical on September 3, 2024 and sell it all today you would earn a total of 0.00 from holding Creo Medical Group or generate 0.0% return on investment in Creo Medical over 90 days. Creo Medical is related to or competes with Atresmedia, Cizzle Biotechnology, Liberty Media, Grand Vision, Park Hotels, Wyndham Hotels, and JD Sports. Creo Medical is entity of United Kingdom More
Creo Medical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Creo Medical's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Creo Medical Group upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.29) | |||
| Maximum Drawdown | 23.32 | |||
| Value At Risk | (7.08) | |||
| Potential Upside | 3.33 |
Creo Medical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Creo Medical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Creo Medical's standard deviation. In reality, there are many statistical measures that can use Creo Medical historical prices to predict the future Creo Medical's volatility.| Risk Adjusted Performance | (0.18) | |||
| Jensen Alpha | (0.80) | |||
| Total Risk Alpha | (1.42) | |||
| Treynor Ratio | 2.15 |
Creo Medical Group Backtested Returns
Creo Medical Group secures Sharpe Ratio (or Efficiency) of -0.26, which signifies that the company had a -0.26% return per unit of standard deviation over the last 3 months. Creo Medical Group exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Creo Medical's risk adjusted performance of (0.18), and Mean Deviation of 2.17 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of -0.4, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Creo Medical are expected to decrease at a much lower rate. During the bear market, Creo Medical is likely to outperform the market. At this point, Creo Medical Group has a negative expected return of -0.88%. Please make sure to confirm Creo Medical's standard deviation, total risk alpha, and the relationship between the coefficient of variation and jensen alpha , to decide if Creo Medical Group performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.89 |
Very good predictability
Creo Medical Group has very good predictability. Overlapping area represents the amount of predictability between Creo Medical time series from 3rd of September 2024 to 18th of October 2024 and 18th of October 2024 to 2nd of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Creo Medical Group price movement. The serial correlation of 0.89 indicates that approximately 89.0% of current Creo Medical price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.89 | |
| Spearman Rank Test | 0.88 | |
| Residual Average | 0.0 | |
| Price Variance | 2.59 |
Creo Medical Group lagged returns against current returns
Autocorrelation, which is Creo Medical stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Creo Medical's stock expected returns. We can calculate the autocorrelation of Creo Medical returns to help us make a trade decision. For example, suppose you find that Creo Medical has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Creo Medical regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Creo Medical stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Creo Medical stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Creo Medical stock over time.
Current vs Lagged Prices |
| Timeline |
Creo Medical Lagged Returns
When evaluating Creo Medical's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Creo Medical stock have on its future price. Creo Medical autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Creo Medical autocorrelation shows the relationship between Creo Medical stock current value and its past values and can show if there is a momentum factor associated with investing in Creo Medical Group.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Creo Stock Analysis
When running Creo Medical's price analysis, check to measure Creo Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Creo Medical is operating at the current time. Most of Creo Medical's value examination focuses on studying past and present price action to predict the probability of Creo Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Creo Medical's price. Additionally, you may evaluate how the addition of Creo Medical to your portfolios can decrease your overall portfolio volatility.